COVID-19

How glucose helps the SARS-CoV-2 to replicate?

EPFL’s Blue Brain Project deployed its powerful brain simulation technology and expertise in cellular and molecular biology to try and answer this question.

Gene editing could stop virus transmission in cells

Discovery points to targeted treatment for COVID-19.

Key mutations in the Alpha variant enable SARS-CoV-2 to overcome evolutionary weak points

The study helps scientists to predict how a new variant might behave in humans when it is first identified.

SARS-CoV-2 can find alternate route to infect cells

COVID-19 drugs, vaccines still effective against mutating viruses.

What makes us sneeze?

Scientists identified neural mechanisms behind sneezing.

How and why some Covid-19 patients can develop life-threatening blood clots?

The study could lead to targeted therapies that prevent this from happening.

Study shed light on the early stages of viral evolution

Scientists studied the structure, assembly and evolution of a "container" composed of a bacterial enzyme.

What makes individuals more susceptible to diverse infections?

Chromosomal changes in white blood cells increase the risk of severe infections.

Raising vitamin D levels through supplementation may not improve COVID-19 outcomes

Investment in other therapeutic or preventative avenues should be prioritized for COVID-19 randomized clinical trials.

Pregnant women’s risk of depression nearly doubled during the COVID-19 pandemic

Women’s risk for depression during pregnancy doubled during the COVID-19 pandemic.

How long will your Coronavirus vaccination last?

Data on the mRNA vaccines are promising.

Recent Stories